Ganesh Benzoplast has scheduled a Board of Directors meeting for September 2, 2026. The session will focus on administrative approvals including the reappointment of the statutory auditor and preparations for the upcoming annual general meeting.

The company issued an intimation under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory filing notifies stock exchanges of the impending corporate action.

Meeting Agenda

The board will consider three primary items during the session:

• Appointment or reappointment of the statutory auditor
• Approval to hold the 39th Annual General Meeting (AGM) and consideration of businesses to be transacted thereat
• Any other matter with the permission of the Chairman

Corporate Governance

Ekta Dhandha, Company Secretary, digitally signed the intimation on August 27, 2026. The notice was dispatched to both the Bombay Stock Exchange and the National Stock Exchange of India Limited.

The Supreme Court of India dismissed an appeal filed by Progfin Private Limited against the National Company Law Appellate Tribunal (NCLAT) order. This verdict on August 18, 2026, ended the legal challenge seeking to initiate a corporate insolvency resolution process (CIRP) against Ganesh Benzoplast .

The company disclosed the outcome in a filing with stock exchanges on August 20, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The apex court stated that the appellant did not have sufficient grounds to contest the NCLAT’s decision.

Litigation Background

The dispute originated from alleged defaults in repayment of credit facilities extended to GBL Chemical Limited, a wholly owned subsidiary of Ganesh Benzoplast. Progfin claimed these facilities were backed by a corporate guarantee purportedly issued by the parent company.

Progfin initially filed a Section 7 petition before the National Company Law Tribunal (NCLT), Mumbai Bench, seeking to initiate CIRP against Ganesh Benzoplast. The NCLT dismissed this petition on September 1, 2025.

Following the NCLT’s rejection, Progfin appealed to the NCLAT. The appellate tribunal upheld the NCLT’s decision and dismissed the appeal on June 30, 2026. Progfin subsequently approached the Supreme Court, which has now closed the matter by dismissing the final appeal.

Financial Implications

Ganesh Benzoplast stated in its regulatory filing that there are no expected financial implications, such as compensation or penalties, arising from this litigation. The company also confirmed that there is no quantum of claims pending against it in relation to this specific dispute.

What the Numbers Show

The complete dismissal of the insolvency petition at all three levels of adjudication—NCLT, NCLAT, and the Supreme Court—indicates a consistent judicial finding that the grounds for initiating CIRP were not substantiated. With no financial penalties or outstanding claims attached to this specific legal battle, the resolution removes a potential overhang on the company’s balance sheet regarding this particular creditor dispute.